ARS We primarily provide our patients with two treatment solutions: (i) artificial insemination (AI), which can be performed with either husband’s sperm (AIH) or a donor sperm (AID); and (ii) IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer (IVF-ET) or IVF with intracytoplasmic sperm injection (ICSI). In addition, we also offer related services such as nutrition guidance, Chinese medicine treatment and psychological counseling to support the ARS.
Management Services During the Track Record Period, we provided joint management services to Jinjiang IVF Center and Jinxin Fertility Center, the fertility center of Jinxin Women and Children Hospital, in return for management service fees pursuant to our IVF specialty collaboration agreements with Jinjiang District Maternity and Child Health Hospital and Jinxin Women and Children Hospital, respectively. In March 2018, we terminated our management services to Jinxin Fertility Center to optimize our business structure and resources, and subsequently the business of Jinxin Fertility Center and the related IVF specialty collaboration agreement were also terminated. We acquired HRC Management in December 2018, which has been providing management services to HRC Medical in the United States pursuant to an MSA since July 2017.
Ancillary Medical Services At Shenzhen Zhongshan Hospital, we also provide medical services in the areas of gynecology, urology and internal medicine.These medical services are designated as our ancillary medical services.